Close

BofA/Merrill Lynch Downgrades Aegerion Pharmaceuticals (AEGR) to Underperform

February 12, 2016 6:54 AM EST Send to a Friend
BofA/Merrill Lynch downgraded Aegerion Pharmaceuticals (NASDAQ: AEGR) from Neutral ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login